Avrobio Inc (DELISTED) (AVRO:DL)
16.80
-0.24
(-1.41%)
USD |
NASDAQ |
Jun 20, 16:00
Avrobio 1 Year Total Returns (Daily): 32.08% for June 20, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 20, 2024 | 32.08% |
| June 18, 2024 | 23.48% |
| June 17, 2024 | 26.96% |
| June 14, 2024 | 30.00% |
| June 13, 2024 | 32.43% |
| June 12, 2024 | 28.21% |
| June 11, 2024 | 22.13% |
| June 10, 2024 | 21.31% |
| June 07, 2024 | 26.67% |
| June 06, 2024 | 33.94% |
| June 05, 2024 | 37.90% |
| June 04, 2024 | 28.83% |
| June 03, 2024 | 32.43% |
| May 31, 2024 | 34.55% |
| May 30, 2024 | 29.73% |
| May 29, 2024 | 24.58% |
| May 28, 2024 | 25.42% |
| May 24, 2024 | 19.84% |
| May 23, 2024 | 7.63% |
| May 22, 2024 | 6.87% |
| May 21, 2024 | 78.04% |
| May 20, 2024 | 79.33% |
| May 17, 2024 | 140.5% |
| May 16, 2024 | 117.5% |
| May 15, 2024 | 121.0% |
| Date | Value |
|---|---|
| May 14, 2024 | 102.8% |
| May 13, 2024 | 112.2% |
| May 10, 2024 | 83.04% |
| May 09, 2024 | 80.38% |
| May 08, 2024 | 77.46% |
| May 07, 2024 | 78.57% |
| May 06, 2024 | 77.14% |
| May 03, 2024 | 83.40% |
| May 02, 2024 | 88.65% |
| May 01, 2024 | 45.45% |
| April 30, 2024 | 19.19% |
| April 29, 2024 | 19.19% |
| April 26, 2024 | 35.96% |
| April 25, 2024 | 33.90% |
| April 24, 2024 | 32.21% |
| April 23, 2024 | 28.12% |
| April 22, 2024 | 27.06% |
| April 19, 2024 | 29.03% |
| April 18, 2024 | 37.17% |
| April 17, 2024 | 31.39% |
| April 16, 2024 | 33.62% |
| April 15, 2024 | 33.62% |
| April 12, 2024 | 42.70% |
| April 11, 2024 | 33.68% |
| April 10, 2024 | 37.36% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.05%
Minimum
May 02 2022
166.7%
Maximum
Oct 16 2023
-20.66%
Average
-28.29%
Median
Jan 27 2021
1 Year Total Returns (Daily) Benchmarks
| Agenus Inc | -52.20% |
| BioCryst Pharmaceuticals Inc | -9.08% |
| AIM ImmunoTech Inc | -42.97% |
| Protalix BioTherapeutics Inc | -43.48% |
| Armata Pharmaceuticals Inc | 118.1% |